Table 1.

Baseline characteristics of patients

	Treatment group
Parameters	CQ	AQ	SP	AQ+SP	AQ+AS
No. of patients	42	39	40	83	83
No. females (%)	20 (47.6%)	22 (56.4%)	26 (65.0%)	42 (50.6%)	38 (46.3%)
Mean age (months. range)	3.8 (0.6–14)	3.3 (0.7–13)	3.8 (0.5–12)	3.9 (0.8–15)	3.9 (0.5–15)
Mean weight (kg. range)	12.9 (7–35)	13.0 (7.8–40)	12.1 (6–34)	14.3 (7–50)	14.6 (6–54.5)
Mean temperature (°C. range)	38.4 (37.5–40.4)	38.4 (37.5–40.8)	38.5 (37.5–40.8)	38.6 (37.5–41.0)	38.6 (37.5–40.9)
Geometric mean parasite density (/μl. range)	21156 (1020–199058)	25559 (1142–199800)	25640 (1010–199531)	22368 (1050–199048)	22905 (1005–184881)
Previous antimalrial therapy (%)	2 (4.7%)	1 (2.9%)	2 (5.0%)	2 (3.9%)	3 (5.3%)
Mean haemoglobin (g/dl. range)	10.1 (6.2–14.0)	10.0 (6.4–14.2)	9.7 (6.2–12.4)	10.2 (6.2–15.6)	10.4 (6.2–15.5)

CQ. Chloroquine; AQ. Amodiaquine; SP. Sulphadoxine-pyrimethamine; AS. artesunate.